Association of SARS-CoV-2 Infection with Neurological Symptoms and Neuroimaging Manifestations in the Pediatric Population: A Systematic Review.
Angela T. H. Kwan,Jacob S. Portnoff,Khaled Al-Kassimi,Gurkaran Singh,Mehrshad Hanafimosalman,Marija Tesla,Nima Gharibi,Tiffany Ni,Ziji Guo,Davaine J. N. Sonfack,Julia Martyniuk,Saman Arfaie,Mohammad Sadegh Mashayekhi,Mohammad Mofatteh,Richie Jeremian,Kevin Ho,Luis Rafael Moscote-Salazar,Angel Lee,Muhammad Youshay Jawad,Felicia Ceban,Kayla M. Teopiz,Rodrigo B. Mansur,Roger Ho,Joshua D. Rosenblat,Bing Cao,Taeho Greg Rhee,Roger S. Mcintyre
DOI: https://doi.org/10.1016/j.jpsychires.2023.12.005
IF: 5.25
2024-01-01
Journal of Psychiatric Research
Abstract:Neurological manifestations have been widely reported in adults with COVID-19, yet the extent of involvement among the pediatric population is currently poorly characterized. The objective of our systematic review is to evaluate the association of SARS-CoV-2 infection with neurological symptoms and neuroimaging manifestations in the pediatric population. A literature search of Cochrane Library; EBSCO CINAHL; Global Index Medicus; OVID AMED, Embase, Medline, PsychINFO; and Scopus was conducted in accordance with the Peer Review of Electronic Search Strategies form (October 1, 2019 to March 15, 2022). Studies were included if they reported (1) COVID-19-associated neurological symptoms and neuroimaging manifestations in individuals aged <18 years with a confirmed, first SARS-CoV-2 infection and were (2) peer-reviewed. Full-text reviews of 222 retrieved articles were performed, along with subsequent reference searches. A total of 843 no-duplicate records were retrieved. Of the 19 identified studies, there were ten retrospective observational studies, seven case series, one case report, and one prospective cohort study. A total of 6985 individuals were included, where 12.8% (n = 892) of hospitalized patients experienced neurocognitive impairments which includes: 1) neurological symptoms (n = 294 of 892, 33.0%), 2) neurological syndromes and neuroimaging abnormalities (n = 223 of 892, 25.0%), and 3) other phenomena (n = 233 of 892, 26.1%). Based on pediatric-specific cohorts, children experienced more drowsiness (7.3% vs. 1.3%) and muscle weakness (7.3% vs. 6.3%) as opposed to adolescents. Agitation or irri-tability was observed more in children (7.3%) than infants (1.3%). Our findings revealed a high prevalence of immune-mediated patterns of disease among COVID-19 positive pediatric patients with neurocognitive abnormalities.